幽门内肉毒杆菌毒素注射治疗胃轻瘫的系统评价。
A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
机构信息
Department of Gastroenterology, Evidence-Based Medicine Group, Changhai Hospital, Second Military Medical University, Shanghai, China.
出版信息
Digestion. 2010;81(1):27-34. doi: 10.1159/000235917. Epub 2009 Dec 22.
BACKGROUND
Though trials evaluating the effect of intrapyloric botulinum toxin injection on gastroparesis have been reported, there is no agreement whether botulinum toxin can effectively relieve the symptoms and improve the results of gastric emptying study in patients with gastroparesis. We performed a systematic literature review to address this issue.
METHODS
Databases including PubMed, EMBASE, and the Cochrane Library and Science Citation Index were searched. Two reviewers independently identified relevant trials. Outcome measures were the improvement of subjective symptoms and objective measurement.
RESULTS
15 reports were included; only 2 randomized controlled trials were available. Almost all the non-randomized trials reported significant improvement in subjective symptoms and objective gastric emptying study after botulinum toxin injection. While the 2 randomized controlled trials did not confirm the efficacy of botulinum toxin injection, none of the individual trials showed that there was statistically significant subjective and objective improvement in the active patients when compared with patients receiving placebo.
CONCLUSIONS
Available high-quality trials showed that intrapyloric botulinum toxin injection could not significantly relieve subjective symptoms and improve objective measurement in patients with gastroparesis, and there is no evidence to recommend botulinum toxin injection for the treatment of gastroparesis.
背景
尽管已经报道了评估幽门内肉毒杆菌毒素注射对胃轻瘫影响的试验,但对于肉毒杆菌毒素是否能有效缓解胃轻瘫患者的症状并改善胃排空研究结果,尚无共识。我们进行了系统的文献回顾来解决这个问题。
方法
检索了包括 PubMed、EMBASE、Cochrane 图书馆和科学引文索引在内的数据库。两名审查员独立识别相关试验。主要结局指标为主观症状和客观测量的改善。
结果
纳入了 15 份报告;仅有 2 项随机对照试验可用。几乎所有非随机试验都报告了肉毒杆菌毒素注射后主观症状和客观胃排空研究的显著改善。虽然这 2 项随机对照试验并未证实肉毒杆菌毒素注射的疗效,但没有任何一项单独的试验表明,与接受安慰剂的患者相比,接受肉毒杆菌毒素注射的患者在主观和客观方面有统计学意义的改善。
结论
现有的高质量试验表明,幽门内肉毒杆菌毒素注射不能显著缓解胃轻瘫患者的主观症状和改善客观测量,没有证据推荐肉毒杆菌毒素注射治疗胃轻瘫。